title: Neutrophil adherence-augmenting and chemotactic plasma activities in acute myocardial infarction: effect of fibrinolytic treatment.
abstract: Polymorphonuclear neutrophils (PMNs) participate in the development of myocardial reperfusion injury during fibrynolytic treatment. In 40 patients with acute myocardial infarction, we evaluated the effect of streptokinase treatment on plasma activity augmenting PMN adherence and chemotactic plasma activity in peripheral venous blood with the use of neutrophils obtained from healthy donors. In all patients we observed the appearance of marked plasma chemotactic activity and plasma activity augmenting PMN adherence. Peak values of both plasma activities in the conventionally treated group were reached on the third day following the onset of symptoms. In streptokinase treated patients both plasma activities reached a peak on the second day after the onset of symptoms. Furthermore, streptokinase in vitro induced adherence of control PMNs in a dose-dependent manner, as well as increasing both chemotaxis and random migration of control cells. Thus, both chemotactic plasma activity and neutrophil adherence augmenting plasma activity may be used for monitoring the inflammatory response to myocardial infarction. However, during fibrynolytic treatment the presence of chemotactic stimuli in peripheral blood may be affected by streptokinase per se.
authors.affiliation: Academy of Medicine, Department of Intensive Therapy, Poznan, Poland.
authors.forename: R
authors.initials: R
authors.lastname: Klimas
authors.forename: T
authors.initials: T
authors.lastname: Siminiak
authors.forename: H
authors.initials: H
authors.lastname: Wysocki
mesh_terms: D002448:Cell Adhesion / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy
chemical_list: D013300:Streptokinase